查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1590838

葡萄糖生物感測器市場：按類型、最終用途分類 - 2025-2030 年全球預測

Glucose Biosensors Market by Type (Electrochemical Biosensor, Optical Biosensor), End Use (Diagnostic Centres, Homecare, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年葡萄糖生物感測器市場規模為168.7億美元，預計2024年將達到192.5億美元，複合年成長率為14.62%，到2030年將達到438.6億美元。

葡萄糖生物感測器是用於測量各種樣本（例如血液）中葡萄糖濃度的分析設備，依賴感測器和生物元件。葡萄糖生物感測器的需求主要是由於糖尿病盛行率的增加以及對連續、非侵入性血糖監測以增強患者依從性和控制的需求所驅動。應用範圍從醫療保健擴展到體育和食品工業等領域，用於監測和分析。典型的最終使用者包括醫院、診斷中心和家庭護理機構。葡萄糖生物感測器市場受到糖尿病盛行率上升、生物感測器技術進步以及穿戴式醫療設備日益普及等因素的影響。新的商機包括整合人工智慧進行預測分析以及開發更易於使用的非侵入式感測器。鼓勵企業投資研發，開發可同時監測多種生物標記的多功能生物感測器，提供更全面的健康監測解決方案。然而，市場開拓面臨著開發成本高、監管障礙以及需要持續進步以滿足消費者對準確性和可靠性日益成長的期望等挑戰。此外，來自替代監測技術和監管環境的競爭也可能阻礙市場滲透。研究和創新應著重於透過小型化和無線通訊技術提高感測器精度、降低成本並提高用戶便利性。探索與高科技公司的合作可以加速生物感測器與智慧設備的整合並擴大市場範圍。市場是動態的，競爭力取決於創新，尤其是在傳統醫療保健環境之外擴展應用。總體而言，如果葡萄糖生物感測器能夠巧妙地克服技術挑戰並滿足注重健康的全球人口不斷變化的需求，那麼它們將呈現出強勁的成長路徑。

主要市場統計
基準年[2023] 168.7億美元
預測年份 [2024] 192.5億美元
預測年份 [2030] 438.6億美元
複合年成長率（%） 14.62%

市場動態：揭示快速發展的葡萄糖生物感測器市場的關鍵市場洞察

供需的動態交互作用正在改變葡萄糖生物感測器市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球糖尿病風險上升
    • 提高對血糖紊亂的認知並及早發現紊亂
    • 自我血糖監測設備在全球的推廣
  • 市場限制因素
    • 對葡萄糖生物感測器設備準確可靠結果的擔憂
  • 市場機會
    • 政府在葡萄糖紊亂的預防和治療方面的積極努力和投資
    • 糖尿病治療的消費者支出不斷成長
  • 市場挑戰
    • 不願意使用新的治療設備，加上血糖監測設備商業化的延遲；

波特五力：駕馭葡萄糖生物感測器市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解葡萄糖生物感測器市場的外部影響

外部宏觀環境因素在塑造葡萄糖生物感測器市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解葡萄糖生物感測器市場的競爭格局

葡萄糖生物感測器市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣葡萄糖生物感測器市場供應商的績效評估

FPNV定位矩陣是評估葡萄糖生物感測器市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了葡萄糖生物感測器市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對葡萄糖生物感測器市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球糖尿病風險上升
      • 提高對糖尿病的認知並及早發現疾病
      • 世界各地自我血糖測量設備的引進正在迅速增加。
    • 抑制因素
      • 對葡萄糖生物感測器設備準確可靠結果的擔憂
    • 機會
      • 政府在糖尿病預防和治療方面的有利措施和投資
      • 消費者在糖尿病治療上的支出不斷成長
    • 任務
      • 抵制使用新治療設備並推遲血糖值監測設備的商業化
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章葡萄糖生物感測器市場：按類型

  • 電化學生物感測器
  • 光學生物感測器

第7章葡萄糖生物感測器市場：依最終用途

  • 診斷中心
  • 居家護理
  • 醫院

第8章美洲葡萄糖生物感測器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區葡萄糖生物感測器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的葡萄糖生物感測器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Aryballe Technologies SA
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • Biosensors International Group Ltd.
  • Danaher Corporation
  • Dexcom, Inc.
  • DuPont de Nemours, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Masimo Corporation
  • Molecular Devices, LLC
  • Pinnacle Technology, Inc.
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-8C74ADFC07A0

The Glucose Biosensors Market was valued at USD 16.87 billion in 2023, expected to reach USD 19.25 billion in 2024, and is projected to grow at a CAGR of 14.62%, to USD 43.86 billion by 2030.

Glucose biosensors are analytical devices used for measuring glucose concentrations in various samples, such as blood, relying on a transducer and biological element. The necessity for glucose biosensors is primarily driven by the increasing prevalence of diabetes and the need for continuous and non-invasive glucose monitoring, enhancing patient compliance and management. Applications extend beyond healthcare into sectors like sports and food industries for monitoring and analysis purposes. Key end-users include hospitals, diagnostic centers, and homecare settings. The market for glucose biosensors is influenced by factors like rising diabetes prevalence, technological advancements in biosensor technology, and increasing adoption of wearable medical devices. Emerging opportunities include the integration of artificial intelligence for predictive analytics and the development of more user-friendly, non-invasive sensors. One recommendation is for businesses to invest in R&D for developing multifunctional biosensors that can monitor several biomarkers simultaneously, providing a more holistic health monitoring solution. However, market growth faces challenges such as high development costs, regulatory hurdles, and the need for continuous advancements to meet increasing consumer expectations for precision and reliability. Additionally, competition from alternative monitoring technologies and the regulatory landscape can hinder market penetration. Research and innovation should focus on improving sensor accuracy, reducing costs, and enhancing user convenience through miniaturization and wireless communication technology. Exploring partnerships with tech firms could foster advancements in biosensor integration into smart devices, expanding market reach. The market is dynamic with a competitive edge hinging on innovation, particularly in expanding applications beyond traditional healthcare settings. Overall, glucose biosensors present a robust growth avenue if technological challenges are adeptly navigated, meeting the evolving demands of a health-conscious global population.

KEY MARKET STATISTICS
Base Year [2023] USD 16.87 billion
Estimated Year [2024] USD 19.25 billion
Forecast Year [2030] USD 43.86 billion
CAGR (%) 14.62%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glucose Biosensors Market

The Glucose Biosensors Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising risk of diabetes worldwide
    • Growing awareness toward glucose disorders coupled with rising early detection of disorders
    • Overgrowing adoption of self glucose monitoring devices worldwide
  • Market Restraints
    • Concerns regarding accurate and reliable results of glucose biosensor devices
  • Market Opportunities
    • Favorable governmental initiatives and investments for prevention and treatment of glucose disorders
    • Expanding consumer expenditures for diabetes treatment
  • Market Challenges
    • Reluctance to use novel treatment devices coupled with slow rate of commercializing the glucose monitoring devices

Porter's Five Forces: A Strategic Tool for Navigating the Glucose Biosensors Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glucose Biosensors Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glucose Biosensors Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glucose Biosensors Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glucose Biosensors Market

A detailed market share analysis in the Glucose Biosensors Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glucose Biosensors Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glucose Biosensors Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glucose Biosensors Market

A strategic analysis of the Glucose Biosensors Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glucose Biosensors Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aryballe Technologies SA, Bayer AG, Bio-Rad Laboratories, Inc., Biosensors International Group Ltd., Danaher Corporation, Dexcom, Inc., DuPont de Nemours, Inc., F. Hoffmann-La Roche Ltd., Masimo Corporation, Molecular Devices, LLC, Pinnacle Technology, Inc., Siemens AG, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Glucose Biosensors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Electrochemical Biosensor and Optical Biosensor.
  • Based on End Use, market is studied across Diagnostic Centres, Homecare, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising risk of diabetes worldwide
      • 5.1.1.2. Growing awareness toward glucose disorders coupled with rising early detection of disorders
      • 5.1.1.3. Overgrowing adoption of self glucose monitoring devices worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns regarding accurate and reliable results of glucose biosensor devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable governmental initiatives and investments for prevention and treatment of glucose disorders
      • 5.1.3.2. Expanding consumer expenditures for diabetes treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Reluctance to use novel treatment devices coupled with slow rate of commercializing the glucose monitoring devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Glucose Biosensors Market, by Type

  • 6.1. Introduction
  • 6.2. Electrochemical Biosensor
  • 6.3. Optical Biosensor

7. Glucose Biosensors Market, by End Use

  • 7.1. Introduction
  • 7.2. Diagnostic Centres
  • 7.3. Homecare
  • 7.4. Hospitals

8. Americas Glucose Biosensors Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Glucose Biosensors Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Glucose Biosensors Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aryballe Technologies SA
  • 3. Bayer AG
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biosensors International Group Ltd.
  • 6. Danaher Corporation
  • 7. Dexcom, Inc.
  • 8. DuPont de Nemours, Inc.
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. Masimo Corporation
  • 11. Molecular Devices, LLC
  • 12. Pinnacle Technology, Inc.
  • 13. Siemens AG
  • 14. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GLUCOSE BIOSENSORS MARKET RESEARCH PROCESS
  • FIGURE 2. GLUCOSE BIOSENSORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES GLUCOSE BIOSENSORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES GLUCOSE BIOSENSORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLUCOSE BIOSENSORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. GLUCOSE BIOSENSORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GLUCOSE BIOSENSORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLUCOSE BIOSENSORS MARKET DYNAMICS
  • TABLE 7. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY ELECTROCHEMICAL BIOSENSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY OPTICAL BIOSENSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY DIAGNOSTIC CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GLUCOSE BIOSENSORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES GLUCOSE BIOSENSORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM GLUCOSE BIOSENSORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM GLUCOSE BIOSENSORS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 100. GLUCOSE BIOSENSORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. GLUCOSE BIOSENSORS MARKET, FPNV POSITIONING MATRIX, 2023